SEC Tracker
Get the app

Silexion Therapeutics SLXN

Silexion adjourns meeting to Oct 26

Additional proxy materials

Form
DEFA14A
Filed
Importance
Routine
  1. Meeting adjourned for one week
  2. Proposals include share capital increase and reverse split
  3. Intended to restore Nasdaq compliance

Written from the DEFA14A on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Silexion Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Acumen Pharmaceuticals ABOS public float $45M, Jun 30, 2025
  2. Alpha Cognition ACOG public float $149M, Jun 30, 2025
  3. Adaptimmune Therapeutics ADAP
  4. Adma Biologics ADMA public float $4.2B, Jun 30, 2025
  5. Adaptive Biotechnologies ADPT public float $1.4B, Jun 30, 2025